论文部分内容阅读
目的:评价甲氨蝶呤联合米非司酮治疗宫外孕的疗效及安全性。方法:将我院2007年11月—2010年10月诊治的宫外孕患者153例分为三组,A组51例单独应用甲氨蝶呤,B组51例单独应用米非司酮,C组51例联合应用甲氨蝶呤、米非司酮,比较三组患者的疗效及不良反应发生情况。结果:C组的总有效率为98.0%,明显高于于A、B组的84.3%、82.4%,组间差异有统计学意义(P<0.05);C组的不良反应发生率与A、B组比较,差异无统计学意义(P>0.05)。结论:甲氨蝶呤联合米非司酮治疗宫外孕临床疗效满意且安全性好,值得临床推广应用。
Objective: To evaluate the efficacy and safety of methotrexate combined with mifepristone in the treatment of ectopic pregnancy. Methods: 153 cases of ectopic pregnancy diagnosed and treated in our hospital from November 2007 to October 2010 were divided into three groups: 51 cases in group A received methotrexate alone, 51 cases in group B received mifepristone alone and group C Cases combined with methotrexate, mifepristone, the efficacy of the three groups were compared and the incidence of adverse reactions. Results: The total effective rate in group C was 98.0%, which was significantly higher than 84.3% and 82.4% in group A and group B respectively (P <0.05). There was no significant difference between group C and group A, B group, the difference was not statistically significant (P> 0.05). Conclusion: Methotrexate combined with mifepristone in the treatment of ectopic pregnancy with satisfactory clinical efficacy and safety is worthy of clinical application.